We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.46%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$18.4B
AUM Growth
+$640M
Cap. Flow
+$72.3M
Cap. Flow %
0.39%
Top 10 Hldgs %
10.88%
Holding
2,903
New
146
Increased
740
Reduced
905
Closed
305

Top Buys

Rank Stock Value
1
TT icon
Trane Technologies
TT
+$81.7M
2
BA icon
Boeing
BA
+$67.3M
3
ATVI
Activision Blizzard
ATVI
+$59.4M
4
UNH icon
UnitedHealth
UNH
+$58.1M
5
SYY icon
Sysco
SYY
+$47.3M

Top Sells

Rank Stock Value
1
KR icon
Kroger
KR
+$88.6M
2
WAB icon
Wabtec
WAB
+$57.7M
3
LUV icon
Southwest Airlines
LUV
+$57.2M
4
HON icon
Honeywell
HON
+$56.3M
5
ORLY icon
O'Reilly Automotive
ORLY
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 14.66%
2 Financials 14.04%
3 Healthcare 12.9%
4 Industrials 11.58%
5 Consumer Discretionary 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FDX icon
301
FedEx
FDX
$74.5B
$16.7M 0.09%
89,788
+5,385
+6% +$988K
SKYW icon
302
Skywest
SKYW
$4.11B
$16.6M 0.09%
456,357
-113,226
-20% -$3.79M
HCA icon
303
HCA Healthcare
HCA
$84.8B
$16.6M 0.09%
224,392
+195,604
+679% +$14.6M
SNPS icon
304
Synopsys
SNPS
$71.5B
$16.3M 0.09%
277,655
-12,618
-4% -$751K
PM icon
305
Philip Morris
PM
$301B
$16.3M 0.09%
178,108
-1,606
-0.9% -$149K
RSG icon
306
Republic Services
RSG
$66.7B
$16.1M 0.09%
283,013
+4,416
+2% +$237K
NSC icon
307
Norfolk Southern
NSC
$78.8B
$16M 0.09%
148,185
-1,883
-1% -$190K
AME icon
308
Ametek
AME
$55.5B
$15.9M 0.09%
326,500
+132,286
+68% +$6.27M
BCR
309
DELISTED
CR Bard Inc.
BCR
$15.9M 0.09%
70,626
-1,433
-2% -$311K
DHR icon
310
Danaher
DHR
$135B
$15.7M 0.09%
227,906
-7,334
-3% -$509K
GLW icon
311
Corning
GLW
$126B
$15.6M 0.08%
642,792
+3,954
+0.6% +$94K
WBA
312
DELISTED
Walgreens Boots Alliance
WBA
$15.2M 0.08%
183,826
+7,647
+4% +$632K
AHT
313
Ashford Hospitality Trust
AHT
$21M
$15M 0.08%
1,953
-54
-3% -$353K
ADI icon
314
Analog Devices
ADI
$181B
$15M 0.08%
206,145
+3,424
+2% +$233K
NPTN
315
DELISTED
NEOPHOTONICS CORP
NPTN
$14.9M 0.08%
1,378,613
+82,601
+6% +$1.1M
SWKS icon
316
Skyworks Solutions
SWKS
$9.06B
$14.7M 0.08%
196,265
-266,858
-58% -$20.5M
VTI icon
317
Vanguard Total Stock Market ETF
VTI
$654B
$14.3M 0.08%
124,083
+525
+0.4% +$59.1K
IT icon
318
Gartner
IT
$9.41B
$14.2M 0.08%
140,236
-2,604
-2% -$252K
ETN icon
319
Eaton
ETN
$157B
$14.1M 0.08%
210,858
-32,011
-13% -$2.1M
EFAV icon
320
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.22B
$13.7M 0.07%
224,226
-158,900
-41% -$10M
DGX icon
321
Quest Diagnostics
DGX
$25.1B
$13.5M 0.07%
146,372
-5,822
-4% -$502K
BRK.A icon
322
Berkshire Hathaway Class A
BRK.A
$1.07T
$13.4M 0.07%
55
+1
+2% +$231K
UGI icon
323
UGI
UGI
$8B
$13.1M 0.07%
284,413
+31,326
+12% +$1.4M
AVGO icon
324
Broadcom
AVGO
$1.82T
$13M 0.07%
732,980
-54,930
-7% -$952K
GSK icon
325
GSK
GSK
$103B
$12.7M 0.07%
264,474
-1,517
-0.6% -$74.9K

Similar funds

Glenmede Trust's Q4 2016 Portfolio in Review

As of Q4 2016, Glenmede Trust held 2,903 positions worth $18.4B, up 3.6% from $17.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Glenmede Trust's Q4 2016 filing shows 146 new, 740 increased, 905 reduced and 305 closed positions. Its largest new stake was CACI: 324,090 shares worth $40.3M. The largest sale was Kroger, an estimated $88.6M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2016 buy was CACI: 324,090 shares worth $40.3M.
  • Glenmede Trust added most to Trane Technologies in Q4 2016, an estimated $81.7M increase.
  • Glenmede Trust's biggest Q4 2016 reduction was Kroger, cutting an estimated $88.6M.
  • Glenmede Trust fully exited Tutor Perini Cor in Q4 2016, selling an estimated $7.9M.
  • Glenmede Trust's ten largest holdings make up 11% of its $18.4B portfolio in Q4 2016.
  • Glenmede Trust opened 146 new positions and closed 305 in Q4 2016.
  • Glenmede Trust's portfolio value rose 3.6% quarter-over-quarter to $18.4B.

Based on Glenmede Trust's 13F filing for Q4 2016, filed 14 Feb 2017.